Long‐acting <scp>PYY<sub>3</sub></scp><sub>−36</sub> analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies

20254 citationsJournal Articlehybrid Open Access

Authors

PYY1875 showed modest efficacy as an add-on to semaglutide for weight management in people with obesity, but the treatment was not well tolerated.

Zero hunger

Published in: Obesity

Volume 33, Issue 8, pp. 1457-1474

Field-Weighted Citation Impact: 5.80